Stock Market Live June 9, 2026: S&P 500 (SPY) Bouncing Back with Tech

Health and Healthcare

Merck : MRK

All Merck Articles

1079 Articles

Paul Ausick | Oct 20, 2011 at 10:58 AM EDT

Lilly’s Drugs Closer to Edge of Patent Cliff (LLY, PFE, JNJ, BMY, SNY, MRK)

Drug maker Eli Lilly & Co. (NYSE: LLY) reported third-quarter earnings this morning, and the company did a little better…

Jon C. Ogg | Oct 12, 2011 at 2:10 PM EDT

Expected Upside Gains for Leading Pharmaceutical Companies (JNJ, PFE, AZN, BMY, MRK)

Sales for the big pharmaceutical companies are expected to be hit by pricing pressure in Europe, a lack of urgent…

Douglas A. McIntyre | Sep 29, 2011 at 6:18 AM EDT

Media Digest (9/29/2011) Reuters, WSJ, NYTimes, FT, Bloomberg

Angela Merkel faces a test: will her own party support money being used for the bailout of Greece? (Reuters) Bernanke…

Jon C. Ogg | Sep 14, 2011 at 1:44 PM EDT

30-Year Auction: 12 of 30 DJIA Stocks Outyield Long Bond (T, CVX, DD, GE, INTC, JNJ, KFT, MRK, PFE, PG, TRV, VZ)

The 30-Year Treasury auction, the so-called Long Bond, had a strong participation for what is technically a 29-year and 11-month…

Jon C. Ogg | Aug 10, 2011 at 5:39 AM EDT

The 2011 Layoff Kings (BSX, CSCO, DAL, GCI, GS, HBC, LMT, MRK, RIMM, SHLD, CS, UBS, MS, ESRX, MHS)

Financial markets have been reeling as investors grow more concerned about the economy: An S&P downgrade of the full faith…

Douglas A. McIntyre | Aug 4, 2011 at 9:26 AM EDT

Lipitor OTC: What Next? (PFE, MRK, AZN, SNY, BMY, LLY, JNJ, AMGN)

Once patent protection expires on a prescription drug, the drug’s maker can take a serious beating in revenue and profitability.…

Jon C. Ogg | Aug 2, 2011 at 10:01 AM EDT

Pharma Earnings Winner: Pfizer Versus Merck (MRK, PFE, LLY)

Merck & Co. Inc. (NYSE: MRK) released second-quarter results last Friday and Pfizer Inc. (NYSE: PFE) reported this morning. The…

Douglas A. McIntyre | Jul 30, 2011 at 8:14 AM EDT

National Employee Morale Day At Merck (MRK)

Merck (NYSE: MRK) released an unusual earnings announcement. It is profitable, has a bright future, and will fire about 13,000…

Jon C. Ogg | Jul 22, 2011 at 1:48 PM EDT

Top Earnings Previews For The Week Ahead (BIDU, NFLX, MMM, AMZN, BIIB, FSLR, F, JNPR, COP, GMCR, V, WFM, ALU, CHK, S, SBUX, TYC, AMGN, ITT, MRK)

Earnings season is in full throttle and many major companies are due to report in the week ahead. Some of…

Jon C. Ogg | Jun 16, 2011 at 8:10 AM EDT

Beyond the Pharma Patent Cliff, Dividends Galore (LLY, BMY, MRK, PFE, ABT)

Many drug companies face a what is called a patent cliff ahead, where the Big Pharma players will have key…

Douglas A. McIntyre | May 25, 2011 at 6:33 AM EDT

Short Sellers Savage The Macro-Caps Across The Board

No industry was able to avoid short selling activity, particularly among its largest companies. Tech, automotive, conglomerates, consumer goods, and…

Jon C. Ogg | May 19, 2011 at 1:39 PM EDT

Top DJIA Dividend Stocks Out-Yielding 10-Year Treasury (T, INTC, JNJ, KFT, MRK, PFE, VZ, CVX, DD, GE, MCD, PG, MO)

Now that the 10-Year Treasury Note has been back to close to the 3.00% yields again, we wanted to see…

Jon C. Ogg | May 10, 2011 at 8:30 AM EDT

Top Analyst Upgrades & Downgrades (ALKS, AEO, ADM, BHP, CSCO, DOW, GBL, ITW, JNY, MRK, PHG, DGX, RGS, RIO, SKS, TSN, VIA-B)

Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Tuesday…

Jon C. Ogg | Apr 18, 2011 at 11:01 AM EDT

Dividend Watch: Lilly Highlights Drug Sector Dividends Ahead of Earnings Season (LLY, PFE, MRK, AZN, GSK)

The drug sector has become rather boring and investors already know all about the ongoing patent expiration threats that loom…

Jon C. Ogg | Mar 24, 2011 at 11:10 AM EDT

Daily Dividend: Will Amgen Finally Start Paying Shareholders? (AMGN, PFE, MRK)

It is time for “The Daily Dividend” and we have an interesting call ahead. How long has it been that…

1 … 59 60 61 62 63 … 72

Merck : MRK

All Merck Articles

Lilly’s Drugs Closer to Edge of Patent Cliff (LLY, PFE, JNJ, BMY, SNY, MRK)

Expected Upside Gains for Leading Pharmaceutical Companies (JNJ, PFE, AZN, BMY, MRK)

Media Digest (9/29/2011) Reuters, WSJ, NYTimes, FT, Bloomberg

30-Year Auction: 12 of 30 DJIA Stocks Outyield Long Bond (T, CVX, DD, GE, INTC, JNJ, KFT, MRK, PFE, PG, TRV, VZ)

The 2011 Layoff Kings (BSX, CSCO, DAL, GCI, GS, HBC, LMT, MRK, RIMM, SHLD, CS, UBS, MS, ESRX, MHS)

Lipitor OTC: What Next? (PFE, MRK, AZN, SNY, BMY, LLY, JNJ, AMGN)

Pharma Earnings Winner: Pfizer Versus Merck (MRK, PFE, LLY)

National Employee Morale Day At Merck (MRK)

Top Earnings Previews For The Week Ahead (BIDU, NFLX, MMM, AMZN, BIIB, FSLR, F, JNPR, COP, GMCR, V, WFM, ALU, CHK, S, SBUX, TYC, AMGN, ITT, MRK)

Beyond the Pharma Patent Cliff, Dividends Galore (LLY, BMY, MRK, PFE, ABT)

Short Sellers Savage The Macro-Caps Across The Board

Top DJIA Dividend Stocks Out-Yielding 10-Year Treasury (T, INTC, JNJ, KFT, MRK, PFE, VZ, CVX, DD, GE, MCD, PG, MO)

Top Analyst Upgrades & Downgrades (ALKS, AEO, ADM, BHP, CSCO, DOW, GBL, ITW, JNY, MRK, PHG, DGX, RGS, RIO, SKS, TSN, VIA-B)

Dividend Watch: Lilly Highlights Drug Sector Dividends Ahead of Earnings Season (LLY, PFE, MRK, AZN, GSK)

Daily Dividend: Will Amgen Finally Start Paying Shareholders? (AMGN, PFE, MRK)

Stock Market Live June 9, 2026: S&P 500 (SPY) Bouncing Back with Tech

Live Nasdaq Composite: AI Stocks Reclaim Lost Ground as Volatility Eases and Oil Pulls Back

The $31 Trillion Message Kevin Warsh Can’t Afford to Ignore

Palantir vs. Apple: Which Stock Offers More Upside in 2026?

We’ve Been Married 40 Years. Why Is My Wife’s Social Security Only $1,000 a Month When Mine Is $3,200?

We've Been Married 40 Years. Why Is My Wife's Social Security Only $1,000 a Month When Mine Is $3,200?

Fidelity's 2026 Study: Americans With a Retirement Plan Are More Than 2 Times as Likely to Feel Confident About Their Future

Ripple (XRP) Is Down 38% in 2026. Will It Break Below $1 This Year?

The $31 Trillion Message Kevin Warsh Can’t Afford to Ignore

Merck : MRK

All Merck Articles

Lilly’s Drugs Closer to Edge of Patent Cliff (LLY, PFE, JNJ, BMY, SNY, MRK)

Expected Upside Gains for Leading Pharmaceutical Companies (JNJ, PFE, AZN, BMY, MRK)

Media Digest (9/29/2011) Reuters, WSJ, NYTimes, FT, Bloomberg

30-Year Auction: 12 of 30 DJIA Stocks Outyield Long Bond (T, CVX, DD, GE, INTC, JNJ, KFT, MRK, PFE, PG, TRV, VZ)

The 2011 Layoff Kings (BSX, CSCO, DAL, GCI, GS, HBC, LMT, MRK, RIMM, SHLD, CS, UBS, MS, ESRX, MHS)

Lipitor OTC: What Next? (PFE, MRK, AZN, SNY, BMY, LLY, JNJ, AMGN)

Pharma Earnings Winner: Pfizer Versus Merck (MRK, PFE, LLY)

National Employee Morale Day At Merck (MRK)

Top Earnings Previews For The Week Ahead (BIDU, NFLX, MMM, AMZN, BIIB, FSLR, F, JNPR, COP, GMCR, V, WFM, ALU, CHK, S, SBUX, TYC, AMGN, ITT, MRK)

Beyond the Pharma Patent Cliff, Dividends Galore (LLY, BMY, MRK, PFE, ABT)

Short Sellers Savage The Macro-Caps Across The Board

Top DJIA Dividend Stocks Out-Yielding 10-Year Treasury (T, INTC, JNJ, KFT, MRK, PFE, VZ, CVX, DD, GE, MCD, PG, MO)

Top Analyst Upgrades & Downgrades (ALKS, AEO, ADM, BHP, CSCO, DOW, GBL, ITW, JNY, MRK, PHG, DGX, RGS, RIO, SKS, TSN, VIA-B)

Dividend Watch: Lilly Highlights Drug Sector Dividends Ahead of Earnings Season (LLY, PFE, MRK, AZN, GSK)

Daily Dividend: Will Amgen Finally Start Paying Shareholders? (AMGN, PFE, MRK)

Stock Market Live June 9, 2026: S&P 500 (SPY) Bouncing Back with Tech

Live Nasdaq Composite: AI Stocks Reclaim Lost Ground as Volatility Eases and Oil Pulls Back

The $31 Trillion Message Kevin Warsh Can’t Afford to Ignore

Palantir vs. Apple: Which Stock Offers More Upside in 2026?

We’ve Been Married 40 Years. Why Is My Wife’s Social Security Only $1,000 a Month When Mine Is $3,200?

Featured Reads

We've Been Married 40 Years. Why Is My Wife's Social Security Only $1,000 a Month When Mine Is $3,200?

Fidelity's 2026 Study: Americans With a Retirement Plan Are More Than 2 Times as Likely to Feel Confident About Their Future